医药生物行业研究:CNS系列报告-抗抑郁药:单胺深化与新机制探索并行 抗抑郁药市场与新药研发进展几何?

西南证券
Nov 14, 2025

抑郁障碍是最常见的精神障碍之一,以持续的心境低落/快感缺失/精力下降为核心临床特征,病因尚不完全明确,存在单胺假说、谷氨酸能系统异常假说等多种假说。抑郁障碍全病程治疗分急性期、巩固期、维持期3个阶段,存在诸多尚未被满足的临床需求:1)SSRIs等现有一线抗抑郁药疗效有限,理论上仍有1/3的患者经多步序贯治疗后无法达到缓解。2)现有抗抑郁药起效慢,通常需要1-4周见到改善、4-8周达到预期治疗目标,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10